Acute leukemia and infection.
D000208:Acute Disease; D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000380:Agranulocytosis; D001228:Aspergillosis / Q000150:complications; D002177:Candidiasis / Q000150:complications; D003561:Cytarabine; D005260:Female; D006801:Humans; D007938:Leukemia / Q000150:complications* / Q000401:mortality; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009091:Mucormycosis / Q000150:complications; D009617:Nocardia Infections / Q000150:complications; D011241:Prednisone / Q000627:therapeutic use; D011512:Proteus Infections / Q000150:complications; D011552:Pseudomonas Infections / Q000150:complications; D018805:Sepsis / Q000150:complications; D013203:Staphylococcal Infections / Q000150:complications; D013322:Strongyloidiasis / Q000150:complications; D014498:Uracil / Q000031:analogs & derivatives / Q000627:therapeutic use; D014747:Vinblastine / Q000627:therapeutic use
D003561:Cytarabine; D014498:Uracil; D014747:Vinblastine; D000324:Adrenocorticotropic Hormone; D015122:Mercaptopurine; D011241:Prednisone; D008727:Methotrexate